University of Munich Medical Center, Dr. von Hauner Children's Hospital, Div. Metabolic and Nutritional Medicine, München, Germany.
Br J Nutr. 2012 Jun;107 Suppl 2:S53-63. doi: 10.1017/S0007114512001468.
Over the last few decades n-3 long chain polyunsaturated fatty acid status became of special interest for scientists. Biochemical measures on the n-3 fatty acid status vary depending on body compartment assessed and measures chosen. Plasma phospholipids and red blood cell membrane phospholipids are mainly used as n-3 fatty acid status marker. The conventional analysis of phospholipid fatty acids involves lipid extraction and consecutive chromatographic separation of phospholipids from other lipid fractions, which is time-consuming and costly. In recent years, different investigators have tried to overcome these limitations by using other biological markers or by modifying the analytical procedures used to assess n-3 fatty acid status. The aim of this systematic review was to provide an overview on these novel analytical methods developed for the fatty acid quantification by gas chromatography, highlights the methodological limitations, and discusses advantages or disadvantages of the biological markers used. Seventeen papers were identified that fulfilled the inclusion criteria. New opportunities arise from sensitive and precise high-throughput methodologies for assessment of plasma total lipid and plasma glycerophospholipid fatty acids, as well as cheek cell fatty acid composition.
在过去的几十年中,n-3 长链多不饱和脂肪酸状况引起了科学家的特别关注。n-3 脂肪酸状况的生化测量取决于所评估的身体部位和所选择的测量方法。血浆磷脂和红细胞膜磷脂主要用作 n-3 脂肪酸状况的标志物。传统的磷脂脂肪酸分析涉及脂质提取和其他脂质部分从磷脂中连续色谱分离,这是耗时且昂贵的。近年来,不同的研究人员试图通过使用其他生物标志物或通过修改用于评估 n-3 脂肪酸状况的分析程序来克服这些限制。本系统评价的目的是提供通过气相色谱法进行脂肪酸定量的这些新分析方法的概述,突出方法学限制,并讨论所使用的生物标志物的优缺点。确定了符合纳入标准的 17 篇论文。通过评估血浆总脂质和血浆甘油磷脂脂肪酸以及颊细胞脂肪酸组成的灵敏和精确的高通量方法,出现了新的机会。